- Report
- December 2024
- 30 Pages
Global
From €2636EUR$2,750USD£2,203GBP
- Report
- January 2024
- 109 Pages
United States
€3355EUR$3,500USD£2,804GBP
The Arnuity market is a subset of the larger Asthma Drugs market. It is composed of long-term, inhaled corticosteroid (ICS) medications used to treat asthma in adults and children. These medications are designed to reduce inflammation in the airways, making it easier for patients to breathe. They are typically taken daily, and are often used in combination with other asthma medications.
The Arnuity market is highly competitive, with several major pharmaceutical companies offering products. These include GlaxoSmithKline, Merck, Novartis, Sanofi, and Teva Pharmaceuticals. Each company offers a range of products, with varying dosages and delivery systems. In addition, generic versions of some of these medications are available.
Companies in the Arnuity market include GlaxoSmithKline, Merck, Novartis, Sanofi, and Teva Pharmaceuticals. Show Less Read more